Latest filings (excl ownership)
25-NSE
Exchange delisting
15 Feb 24
8-K
Regulation FD Disclosure
22 Dec 23
8-K
Completion of Acquisition or Disposition of Assets
19 Dec 23
8-K
Submission of Matters to a Vote of Security Holders
4 Dec 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
17 Nov 23
S-8 POS
Registration of securities for employees (post-effective amendment)
17 Nov 23
S-8 POS
Registration of securities for employees (post-effective amendment)
17 Nov 23
DEF 14A
Definitive proxy
17 Nov 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
9 Nov 23
PRE 14A
Preliminary proxy
6 Nov 23
8-K
Departure of Directors or Certain Officers
1 Nov 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
6 Oct 23
8-K
Amendments to Articles of Incorporation or Bylaws
18 Sep 23
8-K
Regulation FD Disclosure
14 Sep 23
8-K
Submission of Matters to a Vote of Security Holders
11 Sep 23
8-K
Axcella Granted Patent for Long COVID Fatigue Treatment
29 Aug 23
ARS
2022 FY
Annual report to shareholders
18 Aug 23
DEF 14A
Definitive proxy
18 Aug 23
PRE 14A
Preliminary proxy
7 Aug 23
8-K
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
4 Aug 23
10-Q
2023 Q2
Quarterly report
3 Aug 23
8-K
Axcella Reports Second Quarter Financial Results and Provides Business Update
3 Aug 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
29 Jun 23
10-Q
2023 Q1
Quarterly report
4 May 23
8-K
Axcella Reports First Quarter Financial Results and Provides Business Update
4 May 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
7 Apr 23
10-K
2022 FY
Annual report
30 Mar 23
8-K
Axcella Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
30 Mar 23
8-K
Departure of Directors or Certain Officers
17 Feb 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
3 Jan 23
8-K
Axcella Announces Program Reprioritization and Corporate Restructuring Move Positions Company to Best Focus on Long COVID Program
15 Dec 22
10-Q
2022 Q3
Quarterly report
1 Nov 22
8-K
Axcella Reports Third Quarter Financial Results and Provides Business Update
1 Nov 22
8-K
Entry into a Material Definitive Agreement
13 Oct 22
424B5
Prospectus supplement for primary offering
13 Oct 22
8-K
Regulation FD Disclosure
29 Sep 22
D
$12M in debt / options, sold $6M, 2 investors
23 Sep 22
8-K
Entry into a Material Definitive Agreement
23 Sep 22
10-Q
2022 Q2
Quarterly report
12 Aug 22
8-K
Axcella Reports Second Quarter Financial Results and Provides Business Update
12 Aug 22
Latest ownership filings
SC 13G/A
FMR LLC
11 Sep 23
4
Margaret Koziel
3 Mar 23
4
Margaret Koziel
24 Feb 23
4
William Hinshaw
24 Feb 23
4
Paul Fehlner
24 Feb 23
SC 13G/A
HarbourVest Partners L.P.
14 Feb 23
4
Paul Fehlner
13 Feb 23
SC 13G/A
FMR LLC
9 Feb 23
SC 13G/A
Societe des Produits Nestle S.A.
2 Feb 23
4
TORBEN STRAIGHT NISSEN
18 Nov 22
4
Robert L. Rosiello
18 Nov 22
4
William Hinshaw
19 Oct 22
4
NOUBAR AFEYAN
17 Oct 22
SC 13D/A
Flagship VentureLabs IV, LLC
17 Oct 22
3
Initial statement of insider ownership
17 Oct 22
3
Robert L. Rosiello
17 Oct 22
3
TORBEN STRAIGHT NISSEN
17 Oct 22
4
Change in insider ownership
17 Oct 22
SC 13D/A
Flagship VentureLabs IV, LLC
23 Sep 22
4
Margaret Koziel
8 Sep 22
4
David R Epstein
3 Jun 22
4
Margaret Koziel
2 Jun 22
4
PAUL J SEKHRI
25 May 22
3
PAUL J SEKHRI
25 May 22
4
Martin Hendrix
23 May 22
3
Martin Hendrix
23 May 22
4
Catherine A. Sohn
23 May 22
4
William D Baird III
23 May 22
4
CRISTINA Rondinone
23 May 22
4
Gary P. Pisano
23 May 22
4
Michael Rosenblatt
23 May 22
3
Michael Rosenblatt
23 May 22
SC 13G/A
HarbourVest Partners L.P.
29 Mar 22
4
David R Epstein
21 Mar 22
4
Robert Crane
18 Mar 22
4
William Hinshaw
18 Mar 22
4
Paul Fehlner
18 Mar 22
4
David R Epstein
18 Mar 22
SC 13D/A
Flagship VentureLabs IV, LLC
18 Mar 22
4
Robert Crane
18 Mar 22